Skip to content
Open access

Impact of Immunosuppression Type on 30-Day Postoperative Outcomes Following Anterior Cervical Discectomy and Fusion: A Retrospective National Cohort Study of 66,162 Patients

Aug 2026 · Global Spine Journal · 2 citations · 28 references
Medicine

TL;DR

Corticosteroid use is independently associated with increased 30-day infectious complications, readmission, and mortality following ACDF, and perioperative risk modification should prioritize minimizing corticosteroid burden over the cessation of biologic therapies.

Abstract

Study Design Retrospective Cohort Study. Objectives Perioperative immunosuppression management in spine surgery lacks robust evidence. Most NSQIP-based ACDF models utilize a binary steroid variable, failing to distinguish corticosteroids from biologics or synthetic DMARDs. This study uses the granular NSQIP immunosuppression category and propensity score matching (PSM) to validate these risks. Methods Primary ACDF patients were identified in ACS NSQIP (2015–2021; N=66,162). The primary exposure was preoperative corticosteroid use; a secondary analysis utilized the 2021 granular immunosuppression variable (n=9,761). The primary outcome was a 30-day composite adverse event (complication, readmission, reoperation, or mortality). Analysis included multivariable logistic regression and 1:3 PSM. Results Preoperative corticosteroid exposure (3.8%) independently predicted the composite outcome (aOR 1.35, 95% CI 1.16–1.56), readmission (aOR 1.37), and medical complications (aOR 1.38; all p<0.001). Risk was driven by sepsis (aOR 2.00), UTI (aOR 1.67), and pneumonia (aOR 1.44), while wound complications and reoperation rates were not elevated. PSM confirmed these findings and revealed a mortality signal (aOR 2.10, p=0.03). Among 2021 patients, corticosteroids significantly increased risk (aOR 1.95; p=0.004), whereas biologic and synthetic DMARDs showed no significant elevation, though these subgroups were severely underpowered (<10%). Conclusions Corticosteroid use is independently associated with increased 30-day infectious complications, readmission, and mortality following ACDF. Null findings for biologics and synthetic DMARDs reflect inadequate power rather than proven safety. Perioperative risk modification should prioritize minimizing corticosteroid burden over the cessation of biologic therapies.

Read PDF

Similar papers

Review Open access Sep 2026

Comments on “Impact of Immunosuppression Type on 30-Day Postoperative Outcomes Following Anterior Cervical Discectomy and Fusion: A Retrospective National Cohort Study of 66,162 Patients”

We read with interest the study by Phadke et al examining the association between immunosuppression type and 30-day outcomes following anterior cervical discectomy and fusion (ACDF). 1 Distinguishing corticosteroid exposure from other immunosuppressive therapies is clinically important; however, two issues warrant clar...

F. Kaplan, Bilge Kurnaz Kaplan · 1 citation
Aug 2026

Association between postoperative ketorolac use and pseudarthrosis following anterior lumbar interbody fusion: retrospective analysis of a multicenter national database.

Korolac is a safe adjunct to pain control following ALIF and Administration was not found to be associated with increased pseudarthrosis or reoperation rates at the 2-year follow-up, and ketorolac appeared to have a protective effect on this outcome.

Trevor Luck, Coleman Cush, Nigel Wang et al. · 0 citations
Sep 2026

Perioperative outcomes and risk stratification following pediatric arteriovenous malformation resection: an ACS NSQIP-P database analysis

Adverse outcomes following pediatric AVM resection are significantly influenced by surgical urgency, preoperative cardiopulmonary status, and operative complexity, demonstrating that potentially modifiable risk factors provides tangible targets for preoperative intervention.

O. Sbaih, Shubhang Bhalla, Stefan T. Prvulovic et al. · 0 citations
Sep 2026

Spinal metastases: perioperative and oncological outcomes after separation surgery versus expanded anterior column resection: a retrospective cohort study.

SS was associated with a lower perioperative burden, with no significant differences in adjusted OS or composite local recurrence compared with EACR, and more extensive tumor resection may not necessarily provide additional benefit and should be weighed against the increased surgical burden.

Gan Xu, Hao Yuan, Peng-Ru Wang et al. · 0 citations
Open access Oct 2026

Timing Matters: Preoperative Lumbar Epidural Steroid Injection and Long-Term Outcomes Following Single-Level Posterior Lumbar Fusion

Study Design Retrospective Cohort Analysis. Objective CESIs are a mainstay of nonoperative treatment for degenerative lumbar spine disease. As increasing numbers of patients undergo sPLF after receiving CESIs, understanding their impact on surgical outcomes is essential. The objective of the present investigation was t...

Mark Miller, John Pignataro, Matthew Meade et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.